FDA Approves Novel Preventive Treatment for Migraine

The U.S. Food and Drug Administration today approved Aimovig (erenumab-aooe) for the preventive treatment of migraine in adults.

The treatment is given by once-monthly self-injections. Aimovig is the first FDA-approved preventive migraine treatment in a new class of drugs that work by blocking the activity of calcitonin gene-related peptide, a molecule that is involved in migraine attacks.

"Aimovig provides patients with a novel option for reducing the number of days with migraine," said Eric Bastings, M.D., deputy director of the Division of Neurology Products in the FDA's Center for Drug Evaluation and Research. "We need new treatments for this painful and often debilitating condition."

The Ultimate Guide to Finding the Best Neurologist in Singapore: Beyond Stroke and Parkinson’s — Managing Headaches, Pain and More

Why Neurology Matters More Than You Think When people hear […]

Stroke: Controlling Risk Factors

Source from: https://www.healthhub.sg/a-z/medical-and-care-facilities/stroke-controllable-risks

Dr Charles Siow

MB BCh BAO ｜ LRCPI ｜ LRCSI

Tailored Care for Headaches, Pain and Neurological Health

This article has been medically reviewed by Dr Charles Siow

Dr Charles Siow has over 20 years of experience as a neurologist, with the past 18 years dedicated to his practice in Singapore. He is committed to improving the lives of his patients by providing comprehensive care across a wide range of neurological disorders.